ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0022

The Effects of MAA-Modified and/or Citrullinated Proteins on Calcium Influx and Peptidyl Arginine Deiminase (PAD) Expression in Macrophage

Andrew Gerber, Michael Duryee, Nozima Aripova, Bryant England, James O'Dell, Ted Mikuls and Geoffrey Thiele, University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2021

Keywords: citrullination, Gene Expression, Monocytes/macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: RA – Etiology & Pathogenesis Poster (0011–0045)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Expressed in synovial fluid mononuclear and other inflammatory cells, peptidyl arginine deiminase (PAD) catalyzes post-translational citrullination of synovial proteins in a calcium (Ca2+)-dependent manner. Prior reports have demonstrated that post-translational modification of proteins with malondialdehyde-acetaldehyde (MAA) are also common in the RA synovium where they co-localize with citrullinated antigen. However, little is known about the effects of MAA modified proteins on PAD expression or intracellular Ca2+ concentrations. The purpose of this study was to examine the intracellular Ca2+ levels, and the PAD-4 mRNA and protein levels in macrophages following treatment with a MAA-modified antigen.

Methods: THP-1 human macrophage cells were treated with unmodified fibrinogen (Fib) as a negative control or MAA-modified fibrinogen (Fib-MAA) for 24 hours. Cells were washed and incubated with a Fluo-4 AM calcium-binding protein for 30 minutes and subjected to live cell imaging on a 710 Ziess confocal microscope. Images were acquired in 10-second intervals for 120 seconds and analyzed using Image J. RTPCR was performed on the cells to determine the expression of PAD-4 as well as the calcium binding proteins Inositol 1,4,5-triphosphate receptor-3 (ITPR3) and calcium/calmodulin-dependent protein kinase (CAMKK)-2. THP-1 cells were subjected to Western Blot for protein expression of PAD-4 using an anti-PAD antibody. Group differences were examined using ANOVA with a post-hoc test to account for multiple comparisons.

Results: Human macrophages incubated with Fib-MAA significantly increased (p< 0.001) the Ca2+ influx compared to unmodified Fib (Figure 1). Exposure to Fib-MAA had no meaningful impact on ITPR3 expression (p >0.05) (Figure 2). In contrast, CAMKK2 expression was significantly (p< 0.001) increased in macrophages stimulated with Fib-MAA compared to cells stimulated with unmodified Fib. Likewise, PAD-4 mRNA expression was significantly (p< 0.01) increased in only the Fib-MAA vs. native Fib. In contrast to the mRNA expression, Western Blot revealed a decrease in PAD-4 protein expression for Fib-MAA vs. unmodified Fib, suggesting protein depletion (Figure 3).

Conclusion: The increase in Ca2+ influx following treatment with a MAA-modified antigen provides a critical element needed for PAD-mediated protein citrullination in human macrophages, while the observed increase in PAD-4 expression provides the requisite catalyst. The lack of effect seen on ITPR3 (which promotes intracellular movement from the endoplasmic reticulum) suggests that the overall increase likely stems from extracellular sources. The increased expression of CAMKK2 following Fib-MAA exposure could account for changes in cellular activity such as cell differentiation, changes in cell cycle and/or cytoskeletal architecture even though the source of calcium is different. Taken together, these data for the first time implicate MAA-modified proteins as promoters of macrophage-mediated citrullination, a process that is critical in RA pathogenesis and that appears to be dependent on increases in both Ca2+ influx and increased PAD expression.

Figure 1. Intracellular calcium increase following 24 hour treatment of THP_1 macrophage with native fibrinogen or MAA modified fibrinogen. Data is expressed as fluorescence of cells with no treatment divided by time 0 fluorescence. *p<0.001 significantly increased compared to Fib. N=5

Figure 2. Expression of mRNA by RTPCR following 24 hour treatment of THP_1 macrophage with native fibrinogen or MAA modified fibrinogen. ITPR3 expression was not significant compared to Fib. CAMKK2 expression **p<0.01 significantly increased compared to Fib treatment. PAD_4 expression *p<0.01 significantly increased compared to Fib treatment. N=5

Figure 3. Western Blot analysis of THP_1 macrophage cell lysates following 24 hour treatment with native fibrinogen or MAA modified fibrinogen.


Disclosures: A. Gerber, None; M. Duryee, None; N. Aripova, None; B. England, Boehringer-Ingelheim, 2; J. O'Dell, None; T. Mikuls, Gilead Sciences, 2, Horizon, 2, 5, Pfizer Inc, 2, Sanofi, 2, Bristol-Myers Squibb, 2; G. Thiele, Regeneron, 6.

To cite this abstract in AMA style:

Gerber A, Duryee M, Aripova N, England B, O'Dell J, Mikuls T, Thiele G. The Effects of MAA-Modified and/or Citrullinated Proteins on Calcium Influx and Peptidyl Arginine Deiminase (PAD) Expression in Macrophage [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-effects-of-maa-modified-and-or-citrullinated-proteins-on-calcium-influx-and-peptidyl-arginine-deiminase-pad-expression-in-macrophage/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effects-of-maa-modified-and-or-citrullinated-proteins-on-calcium-influx-and-peptidyl-arginine-deiminase-pad-expression-in-macrophage/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology